Understanding how autophagy affects the replication of Hepatitis B virus
Autophagy and the Replication of Hepatitis B Virus
This study is looking at how the Hepatitis B virus uses a process in our cells called autophagy to help it multiply, with the hope of finding new ways to treat people who have chronic Hepatitis B infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10763782 on NIH RePORTER |
What this research studies
This research investigates the role of autophagy in the replication of the Hepatitis B virus (HBV), which affects millions worldwide. By studying cell cultures and transgenic mice, the researchers aim to uncover how HBV utilizes autophagy to enhance its replication. The goal is to identify new therapeutic targets that could lead to better treatments for chronic HBV infections. This work is crucial as current therapies often fail to provide lasting responses in patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are chronically infected with Hepatitis B virus and are seeking better treatment options.
Not a fit: Patients who are not infected with Hepatitis B virus or those who have resolved infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for chronic Hepatitis B virus infections.
How similar studies have performed: Previous studies have shown that understanding viral replication mechanisms can lead to significant advancements in treatment, suggesting potential success for this approach.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Ou, J.-H. James — University of Southern California
- Study coordinator: Ou, J.-H. James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.